查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1944152

全球新型藥物遞送系統市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Novel Drug Delivery Systems in Cancer Therapy Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 86 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計用於癌症治療的新型藥物輸送系統的市場規模將從 2025 年的 270.7 億美元成長到 2034 年的 1748 億美元，2026 年至 2034 年的複合年成長率為 23.03%。

隨著對高效標靶癌症治療的需求持續成長，腫瘤領域新型藥物傳遞系統市場正經歷強勁成長。這些先進的藥物傳遞系統旨在提高抗癌藥物的生物利用度和治療效果，同時最大限度地減少副作用。癌症患者數量的不斷增加以及對個人化醫療日益成長的關注，正在推動奈米顆粒、脂質體和膠束等創新藥物遞送技術的發展。隨著研究人員和製藥公司將癌症治療的進步作為優先事項，新型藥物遞送系統的市場預計將會擴大。

技術進步在塑造腫瘤治療領域新型藥物遞送系統的未來中發揮關鍵作用。製劑技術和標靶化策略的創新提高了藥物傳遞的精準度，實現了腫瘤局部治療，同時保護了健康組織。此外，刺激反應系統和即時監測等智慧技術的整合，也提高了癌症治療的療效和安全性。隨著製造商持續加大研發投入，預計新型藥物遞送系統在各種癌症治療方法的應用將持續擴展。

此外，產學合作的加強正在影響癌症治療領域新型藥物遞送系統的市場。隨著研究人員和製藥公司攜手開發和檢驗新的遞送技術，創新步伐預計將會加快。這一趨勢正在推動建立夥伴關係關係，將研究成果轉化為臨床應用。隨著市場的不斷發展，技術整合、合作以及以患者為中心的理念將是成功的關鍵。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球新型藥物遞送系統市場（癌症治療領域）產品分類

  • 市場分析、洞察與預測
  • 奈米顆粒（脂質體、聚合物、膠束和其他奈米顆粒）
  • 栓塞顆粒（聚乙烯醇顆粒、藥物釋放型微球、液態栓塞劑、其他栓塞顆粒）

5. 全球癌症治療新型藥物遞送系統市場（按地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第6章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第7章 公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Teva Pharmaceutical Industries Ltd
    • Johnson & Johnson Services Inc
    • Galen
    • Merrimack Pharmaceuticals Inc
    • Shire
    • Samyang Biopharmaceuticals Corporation
    • Celgene Corporation
    • Spectrum Pharmaceuticals Inc
    • Other Market Players
簡介目錄
Product Code: VMR11218543

The Novel Drug Delivery Systems in Cancer Therapy Market size is expected to reach USD 174.80 Billion in 2034 from USD 27.07 Billion (2025) growing at a CAGR of 23.03% during 2026-2034.

The Novel Drug Delivery Systems in Cancer Therapy Market is experiencing robust growth as the demand for effective and targeted cancer treatments continues to rise. These advanced drug delivery systems are designed to improve the bioavailability and therapeutic efficacy of anticancer agents while minimizing side effects. The increasing prevalence of cancer and the growing focus on personalized medicine are driving the development of innovative drug delivery technologies, such as nanoparticles, liposomes, and micelles. As researchers and pharmaceutical companies prioritize the advancement of cancer therapies, the market for novel drug delivery systems is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the novel drug delivery systems in cancer therapy market. Innovations in formulation technologies and targeting strategies are enhancing the precision of drug delivery, allowing for localized treatment of tumors while sparing healthy tissues. Additionally, the integration of smart technologies, such as stimuli-responsive systems and real-time monitoring, is improving the effectiveness and safety of cancer therapies. As manufacturers continue to invest in research and development, the market is likely to see increased adoption of novel drug delivery systems across various cancer treatment modalities.

Moreover, the growing emphasis on collaboration between academia and industry is influencing the novel drug delivery systems in cancer therapy market. As researchers and pharmaceutical companies work together to develop and validate new delivery technologies, the pace of innovation is expected to accelerate. This trend is driving the establishment of partnerships and collaborations that facilitate the translation of research findings into clinical applications. As the market continues to evolve, the integration of technology, collaboration, and patient-centric approaches will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Nanoparticles (Liposomes, Polymer, Micelles, Other nanoparticles)
  • Embolization particles (PVA particles, Drug-eluting beads, Liquid emboli, Other Embolization particles)

COMPANIES PROFILED

  • Teva Pharmaceutical Industries Ltd, Johnson Johnson Services Inc, Galen, Merrimack Pharmaceuticals Inc, Shire, Samyang Biopharmaceuticals Corporation, Celgene Corporation, Spectrum Pharmaceuticals Inc, Other market players

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL NOVEL DRUG DELIVERY SYSTEMS IN CANCER THERAPY MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Nanoparticles (Liposomes, Polymer, Micelles, Other nanoparticles) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Embolization particles (PVA particles, Drug-eluting beads, Liquid emboli, Other Embolization particles) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NOVEL DRUG DELIVERY SYSTEMS IN CANCER THERAPY MARKET: BY REGION 2022-2034(USD MN)

  • 5.1. Regional Outlook
  • 5.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 5.2.1 By Product
    • 5.2.2 United States
    • 5.2.3 Canada
    • 5.2.4 Mexico
  • 5.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 5.3.1 By Product
    • 5.3.2 United Kingdom
    • 5.3.3 France
    • 5.3.4 Germany
    • 5.3.5 Italy
    • 5.3.6 Russia
    • 5.3.7 Rest Of Europe
  • 5.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 5.4.1 By Product
    • 5.4.2 India
    • 5.4.3 Japan
    • 5.4.4 South Korea
    • 5.4.5 Australia
    • 5.4.6 South East Asia
    • 5.4.7 Rest Of Asia Pacific
  • 5.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 5.5.1 By Product
    • 5.5.2 Brazil
    • 5.5.3 Argentina
    • 5.5.4 Peru
    • 5.5.5 Chile
    • 5.5.6 South East Asia
    • 5.5.7 Rest of Latin America
  • 5.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 5.6.1 By Product
    • 5.6.2 Saudi Arabia
    • 5.6.3 UAE
    • 5.6.4 Israel
    • 5.6.5 South Africa
    • 5.6.6 Rest of the Middle East And Africa

Chapter 6. COMPETITIVE LANDSCAPE

  • 6.1. Recent Developments
  • 6.2. Company Categorization
  • 6.3. Supply Chain & Channel Partners (based on availability)
  • 6.4. Market Share & Positioning Analysis (based on availability)
  • 6.5. Vendor Landscape (based on availability)
  • 6.6. Strategy Mapping

Chapter 7. COMPANY PROFILES OF GLOBAL NOVEL DRUG DELIVERY SYSTEMS IN CANCER THERAPY INDUSTRY

  • 7.1. Top Companies Market Share Analysis
  • 7.2. Company Profiles
    • 7.2.1 Teva Pharmaceutical Industries Ltd
    • 7.2.2 Johnson & Johnson Services Inc
    • 7.2.3 Galen
    • 7.2.4 Merrimack Pharmaceuticals Inc
    • 7.2.5 Shire
    • 7.2.6 Samyang Biopharmaceuticals Corporation
    • 7.2.7 Celgene Corporation
    • 7.2.8 Spectrum Pharmaceuticals Inc
    • 7.2.9 Other Market Players